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RESEARCH ARTICLE
Recovery from acidosis is a robust trigger for loss of
force in murine hypokalemic periodic paralysis
Wentao Mi1, Fenfen Wu2, Marbella Quinonez2, Marino DiFranco2, and Stephen C. Cannon2
Periodic paralysis is an ion channelopathy of skeletal muscle in which recurrent episodes of weakness or paralysis are caused
by sustained depolarization of the resting potential and thus reduction of fiber excitability. Episodes are often triggered by
environmental stresses, such as changes in extracellular K+, cooling, or exercise. Rest after vigorous exercise is the most
common trigger for weakness in periodic paralysis, but the mechanism is unknown. Here, we use knock-in mutant mouse
models of hypokalemic periodic paralysis (HypoKPP; NaV1.4-R669H or CaV1.1-R528H) and hyperkalemic periodic paralysis
(HyperKPP; NaV1.4-M1592V) to investigate whether the coupling between pH and susceptibility to loss of muscle force is a
possible contributor to exercise-induced weakness. In both mouse models, acidosis (pH 6.7 in 25% CO2) is mildly protective,
but a return to pH 7.4 (5% CO2) unexpectedly elicits a robust loss of force in HypoKPP but not HyperKPP muscle. Prolonged
exposure to low pH (tens of minutes) is required to cause susceptibility to post-acidosis loss of force, and the force
decrement can be prevented by maneuvers that impede Cl− entry. Based on these data, we propose a mechanism for post-
acidosis loss of force wherein the reduced Cl− conductance in acidosis leads to a slow accumulation of myoplasmic Cl−. A rapid
recovery of both pH and Cl− conductance, in the context of increased [Cl]in/[Cl]out, favors the anomalously depolarized state
of the bistable resting potential in HypoKPP muscle, which reduces fiber excitability. This mechanism is consistent with the
delayed onset of exercise-induced weakness that occurs with rest after vigorous activity.
Introduction
The familial periodic paralyses are rare inherited disorders of
skeletal muscle in which mutations of ion channels (NaV1.4,
CaV1.1, or Kir2.1) result in susceptibility to recurrent episodes of
weakness or even paralysis (Cannon, 2015). In all forms of pe-
riodic paralysis, the transient attacks of weakness are caused by
sustained depolarization of the resting potential (Vrest) and the
accompanying loss of fiber excitability (Lehmann-Horn et al.,
1983; Rüdel et al., 1984). While spontaneous episodes do occur,
many attacks are induced by environmental triggers, such as
diet (carbohydrate or salt content), exercise, muscle cooling, or
stress. Exercise is one of the most consistent provocative factors
(Miller et al., 2004). Curiously, the weakness does not begin
during exercise. In fact, an impending attack of weakness can be
attenuated by performing light exercise. Susceptibility to
exercise-induced weakness occurs a few minutes after stopping
to rest, especially after a prolonged period (tens of minutes or
longer) of vigorous exercise.
Despite the fact that exercise is a common trigger for all
forms of familial periodic paralysis, the mechanism is unknown.
Previous suggestions have included the efflux of K+ out of
working muscle, adrenaline release, or a decrease in local pH
(Ricker et al., 1989). Two lines of evidence support the notion
that acidosis may be protective and thereby explain why attacks
do not occur during exercise. First, carbonic anhydrase in-
hibitors, such as acetazolamide, reduce attack frequency and
severity for ∼50% of patients with hypokalemic periodic pa-
ralysis (HypoKPP; Matthews et al., 2011) or hyperkalemic peri-
odic paralysis (HyperKPP; Sansone et al., 2016). At therapeutic
dosages, carbonic anhydrase inhibitors cause systemicmetabolic
acidosis, and this effect has been proposed to be an essential
feature for the therapeutic benefit (Griggs et al., 1970). Clinical
studies support this hypothesis, as shown by the fact that met-
abolic acidosis produced by oral administration of NH4Cl for 3 d
also provided protection from provoking an attack of HypoKPP
(Jarrell et al., 1976). Maren and colleagues have proposed the
benefit of acidosis for HypoKPP comes from an effect on K+ flux
(Vroom et al., 1975; Jarrell et al., 1976). Acidosis decreases the
influx of K+ into many tissues, including skeletal muscle. Dur-
ing an attack of HypoKPP, serum K+ is low because K+ shifts
into muscle fibers (Zierler and Andres, 1957), which in a
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positive-feedback loop aggravates the paradoxical depolarization
and decreases contractility. Attenuation of the K+ influx by aci-
dosis may therefore be beneficial. Additional support for this
hypothesis comes from our HypoKPP mouse models (Wu et al.,
2013a) because acetazolamide is effective in vivo but much
less so for the ex vivo tissue bath assay (where [K+]o is fixed and
acetazolamide does not produce acidosis). A second line of evi-
dence shows benefit from acidosis in HyperKPP. In vitro studies
on human intercostal fibers from a patient with HyperKPP
showed that a reduction of pH, using CO2 or HCl, attenuated or
prevented the loss of force triggered by elevated [K+]o
(Lehmann-Horn et al., 1987). The improvement in force gener-
ation occurred even though the excessive depolarization of Vrest
persisted at low pH. The authors proposed that a left shift in the
apparent voltage dependence of sodium channel inactivation
from higher extracellular [H+] could explain the improvement of
fiber excitability.
In this study, we initially set out to define the mechanism
by which acidosis may be protective against an attack of
weakness induced by known triggers, such as reduced K+. The
approach was to perform in vitro contraction studies with our
knock-in mutant mouse models of periodic paralysis
(Hayward et al., 2008; Wu et al., 2011, 2012), where envi-
ronmental variables such as [K+], pH, and temperature could
be controlled in an organ bath. While acidosis (bicarbonate
bath gassed with 25% CO2) increased the force in HyperKPP
muscle (NaV1.4-M1592V) and did provide modest protection
from a low K+ (2 mM)–induced loss of force in the soleus
muscle from HypoKPP mice (NaV1.4-R669H), the more robust
finding was a transient loss of force elicited by the return to
normal pH (5% CO2). This post-acidosis loss of force occurred
in both models of HypoKPP (NaV1.4-R669H and CaV1.1-
R528H), but not for HyperKPP (NaV1.4-M1592V). A prolonged
exposure to low pH was required to induce susceptibility to
loss of force, and the force decrement could be prevented with
ionic conditions or drugs that impede the entry of Cl− into
muscle.
We propose a mechanism for the post-acidosis loss of force,
based on accumulation of myoplasmic Cl− during acidosis.
Acidosis is known to decrease the chloride conductance of
muscle, GCl, which is the dominant membrane conductance in
resting fibers (Palade and Barchi, 1977; Pedersen et al., 2005).
A lower GCl impedes the major efflux pathway and promotes
Cl− accumulation (Aickin et al., 1989) resulting from the basal
influx via the Na+-K+-2Cl− (NKCC1) cotransporter. My-
oplasmic [Cl−] is normally low, ∼4 mM, and so after several
minutes the relative change in concentration is sufficient
to substantially depolarize the equilibrium potential, ECl.
The resting potential, Vrest, does not change much during ac-
idosis (low GCl), but upon rapid recovery from acidosis, GCl
rapidly increases and the established shift of ECl causes de-
polarization of Vrest. HypoKPP muscle has a bistable Vrest, with
the anomalous depolarized state caused by a gating pore
current from mutant channels (Cannon, 2018). Consequently,
HypoKPP fibers, but not WT, become stably depolarized, re-
fractory, and unable to contract because of NaV channel
inactivation.
Materials and methods
Mouse models of periodic paralysis
The generation of knock-in mutant mouse lines, molecular
confirmation of mutant allele expression, and functional
characterization of the skeletal muscle phenotype with periodic
paralysis have been previously described (Hayward et al.,
2008; Wu et al., 2011, 2012). Knock-in mutant mice were
backcrossed with 129/Sv mice for more than 15 generations to
produce congenic lines. We adopted a nomenclature for our
mouse lines based on the missense mutation in the human
channel so that cross-referencing to the patient literature on
periodic paralysis would be facilitated. Our mouse model for
HyperKPP plus myotonia contained a point mutation in SCN4A
that encoded M1592V in the human NaV1.4 sodium channel
(M1586V in mouse; Hayward et al., 2008). We created two
mouse models of HypoKPP, one with a missense mutation of
SCN4A encoding the equivalent of human R669H in NaV1.4
(R663H in the mouse; Wu et al., 2011) and a second with a
missense mutation in CACNA1S encoding the R528H mutations
in CaV1.1 (Wu et al., 2012).
In vitro contraction studies
Mice were euthanized with isoflurane inhalation followed by
cervical dislocation. The soleus muscle was quickly removed
and suspended vertically between a fixed post and a force
transducer (Fort 25, World Precision Instruments or 305C
Dual Mode Lever-Arm System, Aurora Scientific) in a tissue
bath maintained at 37°C. The standard bath solution was a
bicarbonate-buffered Krebs solution containing (in mM) 118
NaCl, 4.75 KCl, 1.18 MgSO4, 2.5 CaCl2, 1.18 NaH2PO4, 24.8
NaHCO3, and 10 glucose. The Krebs solution was supplemented
with 0.5 µM D-tubocurarine, except for the compound muscle
action potential (CMAP) experiments in Fig. 4 (see below), to
provide consistency of direct field stimulation to muscle fibers
rather than have an uncontrolled contribution from motor
nerve endings (Wu et al., 2011). For some of the fibers included
in Figs. 1 and 2 A, the Krebs bath was also supplemented with
20 U/liter (158 nM) insulin to prolong viability of the ex vivo
preparation. Subsequently, we found there was no improve-
ment, and so insulin was omitted for the majority of the data in
this paper. Moreover, there was no difference in the loss of
force elicited by recovery from acidosis with or without insu-
lin. The tissue bath was continuously bubbled with a mixture of
N2, O2, and CO2 that was set by a computer-controlled gas
mixer (Gas Blender Series 100, MCQ Instruments). The stan-
dard mixture was 95% O2/5% CO2, and periods of acidosis were
imposed by rapid exchange with the same Krebs solution that
had been preequilibrated with 7.5–40% CO2 by using a com-
mensurate reduction in the percentage of O2. The possibility
that changes in muscle force were from hypoxia, rather than
acidosis, was excluded by showing the same changes were
produced when the O2 was kept constant but CO2 and N2 were
varied: 75% O2/20% N2/5% CO2 exchanged with 75% O2/25%
CO2. Tetanic contraction was induced by constant-current
stimulation (80 mA; model A385 World Precision Instru-
ments or model 301C Aurora Scientific) with 0.5-ms pulses
(40 × 100 Hz) applied to a pair of platinum pins oriented
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perpendicular to the muscle long axis. Figs. 2, 3, 5, and 6 show
relative force ([peak force for test]/[peak force for control]),
and the error bars indicate standard error of the mean.
In vitro CMAP
The soleus muscle with a stump of the intact sciatic nerve was
dissected from themouse andmounted to a force transducer in a
horizontal tissue chamber (Kent Scientific). The nerve was
drawn into a suction electrode and stimulated (8 mA) at
100 Hz × 60 pulses of 0.5-ms duration (A385 Stimulator; World
Precision Instruments). Muscle excitability was assessed by
measuring the CMAP as a differential voltage between two
electromyography needles inserted into the soleus, with both
on the same side relative to the neuromuscular junction. The
differential signal was amplified (3-Hz to 3-KHz bandwidth;
Grass P511) and sampled at 10 KHz. The tissue bath contained
the standard Krebs solution at 37°C as above, except the
D-tubocurarine was omitted.
Intracellular pH (pHi)
Myoplasmic pH was measured with the ratiometric fluorescent
probe BCECF (29,79-Bis-(2-Carboxyethyl)-5-(and-6)-Carboxy-
fluorescein) (Westerblad and Allen, 1992). Fibers from the flexor
digitorum brevis were loaded with AM-BCECF (10 µM, Ther-
moFisher Scientific) in HEPES buffered saline (in mM): 135
NaCl, 5 KCl, 1.8 CaCl2, 0.5 MgCl2, 0.4 NaH2PO4, 5.5 glucose, 20
HEPES, pH 7.4 with NaOH for 30 min at 37°C. Fibers were then
imaged using an Andor Neo sCMOS spinning-disc confocal mi-
croscope (dual excitation at 445 nm and 488 nm and emission
filter 535 nm) in the UT Southwestern Live Cell Imaging Core
Facility. Images were acquired every 2 min over a 1-h session
during which a 25% CO2 challenge was applied for 20 min.
Calibration was then performed at the end of every experi-
mental run by applying the H+ ionophore nigericin (10 µM) and
then superfusing the fibers with high K+ solutions (in mM: 140
KCl, 0.5MgCl2, 1.2 KHPO4, 20 pH buffer, pHwith KOH) buffered
with Mes (pH 4.5, 5.5), a 50/50 mixture of Mes and HEPES (pH
Figure 1. Acidosis attenuates the loss of force elicited by a low-K+ challenge. Isometric contractions were recorded once every 2 min in response to
tetanic stimulation (0.5-ms pulses at 100 Hz × 40) of the isolated soleus muscle ex vivo. (A) Reduction of [K+]o from 4.7 to 2 mM revealed the HypoKPP
phenotype as a large decrease in force (∼50%, left), as shown by exemplary responses from two different heterozygous mice (NaV1.4-R669H/WT). When the
paired muscles from the opposite limb of these same two mice were preequilibrated in acidified Kreb’s solutions (25% CO2/75% O2, pH 6.71), the loss of force
for a 2-mM K+ challenge was attenuated to 30% (right). The return to normal Kreb’s (5% CO2/95% O2, pH 7.43; asterisk) triggered a second transient loss of
force. (B) Recovery from acidosis alone, without a hypokalemic challenge, also elicited a transient decrease in force. Data show consecutive acidosis challenges
applied to the same soleus muscle from a heterozygous NaV1.4-R669H/WT mouse. (C) Force transients recorded during the control interval (120-min trace)
and at the nadir of the transient decrease in force (176-min trace).
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6.5, 7.5) or Tris (pH 8.5, 9.36) in a high K solution (Westerblad
and Allen, 1992). After subtraction of background fluorescence,
the fluorescence ratio, R = F488/F445, was calculated using
ImageJ and the calibration data were fit to the following
equation:
pHi  pKa + log[(R − Rmin)
 (Rmax − R)].
Study approval
All procedures were in accordance with animal protocols ap-
proved by the Institutional Animal Care and Use Committees at
the David Geffen School of Medicine, University of California,
Los Angeles, CA and University of Texas Southwestern Medical
Center, Dallas, TX.
Results
Acidosis attenuates the loss of force in HypoKPP muscle
during low-K+ exposure
Strenuous exercise is a well-known precipitant for attacks of
periodic paralysis in susceptible individuals, with the weakness
occurring after several minutes of rest but not during ongoing
activity (Cannon, 2015). Nothing is known about the mechanism
of this phenomenon, and our initial approach was to explore the
possibility that muscle acidosis protects against the loss of force
during exercise (Jarrell et al., 1976). We tested this hypothesis by
using an in vitro contraction assay previously developed for our
knock-in mutant mouse model of HypoKPP caused by the so-
dium channel NaV1.4-R669H mutation (Wu et al., 2011). The
force of an isometric tetanic contraction in the isolated soleus
muscle was stable over 40 min (shown as relative force for two
soleus muscles from different animals in Fig. 1 A, left) but
transiently decreased when the bath [K+] was reduced from 4.7
to 2 mM (40–80 min), which shows the HypoKPP phenotype.
The soleus from the opposite hindlimb was tested in a separate
organ bath for which acidosis was imposed by exchanging the
bath with bicarbonate-buffered solution equilibrated with 25%
CO2/75% O2 (pH 6.71) instead of the control 5% CO2/95% O2 (pH
7.43). Acidosis was well-tolerated as shown by the sustained
level of contractile force (Fig. 1 A, right, 20–40min), and the loss
of force induced by a subsequent 2-mM [K+] challenge was at-
tenuated (40–80 min). In each of the four NaV1.4-R669H mice
tested, pretreatment with 25% CO2 always attenuated the loss of
force from a 2-mM K+ challenge, similar to the exemplary re-
sponses shown in Fig. 1 A. On average, the relative force nadir
was 0.53 ± 0.039 in 5% CO2 and 0.71 ± 0.054 in 25% CO2;
P < 0.05.
Unexpectedly, a transient decrease in tetanic force consis-
tently occurred upon recovery from acidosis when the bath was
rapidly returned to Kreb’s solution equilibrated with 5% CO2/
95% O2 (Fig. 1 A, asterisk in the right panel). We next examined
whether the low-K+ challenge was necessary for this pH-
dependent loss of force. A 20-min interval of acidosis alone
(25% CO2/75%O2) was sufficient, and a second acidosis challenge
applied to the same muscle 2 h later produced an even larger
decline in force (Fig. 1 B). Example force transients selected at
times 120 min (control) and 176 min (nadir for transient loss) are
shown in Fig. 1 C. The rise time and decay time of the force
transient during the nadir of peak force were indistinguishable
from control conditions, and there was no sag in the peak force
during a 400-ms tetanic contraction.
Recovery from acidosis triggers a large transient loss of force
in HypoKPP muscle
The acidosis challengewas applied to soleusmuscle from several
mouse models of periodic paralysis and WT mice to determine
which genotypes have susceptibility to the transient loss of force
upon return to normal pH. Two established models of murine
HypoKPP were examined: NaV1.4-R669H (Wu et al., 2011) and
CaV1.1-R528H (Wu et al., 2012). For both HypoKPP lines, soleus
muscle from homozygous mutant animals was used herein and
for the remainder of our studies to maximize the sensitivity of
detecting an anomalous force response. The HyperKPP mouse
model was studied in the heterozygous state (NaV1.4-M1592V/WT)
Figure 2. Recovery from acidosis triggers a transient loss of force in HypoKPP muscle. (A) Peak tetanic force was maintained for soleus muscle from all
mice during a 30-min challenge with 25% CO2. Upon return to 5% CO2, a transient loss of force occurred for muscle from both HypoKPP mouse models (n = 6
for each), but notWT (n = 7) or HyperKPP (n = 6). (B) A comparable decrease of pHi, as measured by BCECF fluorescence, occurred for HypoKPP andWTmuscle
during a 25% CO2 challenge. (C) The dose–response relation measured over a range of 20-min CO2 challenges (5% to 40%) for NaV1.4-R669H HypoKPP soleus
muscle shows a threshold for detecting a loss of force at 11% (−0.36 pH units) and near complete loss of force after a 40% challenge (−1.0 pH units).
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because survival of homozygous mutant animals is very
poor (Hayward et al., 2008). Maximal tetanic force of the soleus
muscle was monitored every 2 min as the bath was exchanged
with Kreb’s solution equilibrated in 25% CO2/75% O2 and then
30 min later returned to Kreb’s solution equilibrated with 5%
CO2/95% O2. Force was maintained within ±15% during the ac-
idosis interval for soleus muscle from all mouse genotypes, but
only the HypoKPP soleus had a large transient decrease in
maximal force upon return to 5% CO2/95% O2 (Fig. 2 A). We
confirmed the transient loss of force was a consequence of the
acidosis in 25% CO2, and not the 20% reduction of O2, by chal-
lenging NaV1.4-R669H soleus with 5% CO2/75% O2/20% N2,
which did not cause a transient loss of force (data not shown).
Onset for the loss of force began with a lag since the bath ex-
change (three times the chamber volume) was completed in∼5 s,
and 6–8 min was required for the force to reach a minimum.
Recovery of force was consistently slower for the CaV1.1-R528H
soleus than NaV1.4-R669H, and the peak force for CaV1.1-R528H
muscle had a slow decline during the acidosis interval. The re-
sponse for HyperKPP soleus consistently had a small increase in
force during the acidosis interval. One possible interpretation is
that in 4.7 mMK+ the baseline force was mildly compromised for
HyperKPP muscle, but not HypoKPP, and acidosis improved
performance analogous to the improvement in low K+ for Hy-
poKPP muscle (Fig. 1 A).
The pHi change in response to the 25% CO2 challenge was
measured with a ratiometric fluorescent dye (BCECF) to deter-
mine whether the susceptibility to a transient loss of force in
HypoKPP muscle was associated with a difference in pHi ho-
meostasis. A rapid exchange of the chamber bath to Kreb’s
buffer equilibrated with 25% CO2 caused a 0.4-U decrease of pHi
(Fig. 2 B) that reached steady state within 2 min (the first
measurement time point) and remained stable during the entire
20-min exposure. In all muscles tested, this hypercapnic load
overwhelmed the compensatory capacity of a fiber to autor-
egulate pHi. A rapid return to Kreb’s buffer equilibrated with 5%
CO2 caused a gradual recovery of pHi to baseline that occurred
over a 10-min period. The responses were indistinguishable for
muscle isolated from either HypoKPP mouse model or WTmice.
In particular, the trajectory for the recovery of pHi, when a
transient loss of force would occur for HypoKPP muscle
(30–40min in Fig. 2 B), was the same for fibers frommutant and
WTmice. These data show that the post-acidosis loss of force for
NaV1.4-R669H or CaV1.1-R528H HypoKPP muscle is not caused
by a difference in pHi regulation compared with WT muscle,
which has no transient loss of force.
The sensitivity of HypoKPP muscle to pH-induced loss of
force was determined by varying the percentage of CO2 between
5% and 40% during the 20-min challenge for NaV1.4-R669H
soleus (Fig. 2 C). The threshold for eliciting a detectable loss of
force was 11.2% CO2 (ΔpHe −0.4). The nadir in force decreased to
50%, with a 16.7% CO2 challenge (ΔpHe −0.6), and in 40% CO2
(ΔpHe −1.0) the force transiently decreased to nearly zero. By
comparison, exhaustive exercise in humans reduces the pHi of
the quadriceps muscle by ∼0.5 (Sahlin et al., 1976), which im-
plies that physiologically relevant changes in pH are sufficient to
trigger a transient loss of force in HypoKPP muscle.
Prolonged acidosis, followed by rapid recovery, promotes a
transient loss of force
The time course for the onset of susceptibility to loss of force
was determined by varying the duration of the acidosis interval
in Kreb’s buffer preequilibrated with 25% CO2. The loss of force
upon return to 5% CO2 became more severe as the acidosis ex-
posure time was increased over many tens of minutes, as shown
in Fig. 3 A. Each muscle preparation was tested with only a
single interval of acidosis to avoid the complication of cumula-
tive effects, as demonstrated by the repeated exposures sepa-
rated by 2 h in Fig. 1 B. The peak tetanic force for soleus muscle
from CaV1.1-R528H mice had a progressive, slow decline during
the period of acidosis (Fig. 3 A, left panel), and so a baseline
correction was made to define the relative loss of force upon
return to 5% CO2 (Fig. 3 A, right panel). The onset for suscep-
tibility to loss of force was exponential with a time constant
of ∼30 min. This slow time course is comparable to the phe-
nomenon of postexercise weakness for individuals with Hy-
poKPP, in which a period of vigorous exercise of 30 min or
longer is typically required to trigger an episode of weakness
during subsequent rest.
Light exercise may abort an impending attack of HypoKPP,
and a gradual “warm down” after vigorous exercise may pre-
vent an acute postexercise episode (Lehmann-Horn et al.,
2004). We therefore wondered whether a gradual recovery of
pH after 30 min of acidosis in 25% CO2 might prevent the
transient loss of force in our mouse model of HypoKPP. A slow
recovery of pH for the muscle bath was achieved by adjusting
the percentage of CO2 in a mixture of O2/N2/CO2 from a
computer-controlled gas mixer that continuously bubbled the
25-ml chamber. A step change in the percentage of CO2 from
25% back to 5% produced an exponential recovery of pH from
6.6 to 7.4 with a time constant of 50 s (Fig. 3 B, left). More
gradual pH changes were applied by using a series of small
incremental step changes in the percentage of CO2 over several
minutes. The pH of the muscle bath was monitored continu-
ously with a reference electrode. A pair of soleus muscles from
the same mouse was tested in parallel, but in separate cham-
bers, with one having a rapid return of pH within 5 s by total
exchange of the bath with preequilibrated Kreb’s buffer and the
other having a slow pH change controlled by the gas mixer.
Slowing the pH recovery time from a few seconds to a few
minutes did not prevent the transient loss of force (Fig. 3 B,
left), and prolongation of the pH recovery time to 20 min was
required attenuate the loss by ∼40% (Fig. 3 B, middle). Ex-
tending the pH recovery time to 50 min greatly reduced the
loss of force and in some individual trials completely prevented
the loss. Collectively, the data in Fig. 3 show that both the onset
of acidosis-induced susceptibility to loss of force and the re-
covery from susceptibility are very slow, with a time course of
many tens of minutes.
HypoKPP muscle fiber excitability is decreased during an
acidosis-triggered loss of force
The episodic attacks of weakness associated with low extra-
cellular [K+] in patients with HypoKPP are caused by sus-
tained depolarization of the resting potential (Vrest), which
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inactivates Na+ channels and reduces fiber excitability (Rüdel
et al., 1984). We tested whether the acidosis-induced loss of
force in mouse HypoKPP muscle was also associated with
reduced fiber excitability. CMAP was measured as an index of
fiber excitability in an ex vivo preparation for which the free
ending of the sciatic nerve was stimulated with a suction
electrode and force was monitored during an isometric con-
traction of the soleus muscle. A 30-min challenge with 25%
CO2 was well tolerated, but upon rapid return to 5% CO2 there
was a concomitant decrease in CMAP amplitude of HypoKPP
muscle (Fig. 4, A and C) and in maximal isometric force (Fig. 4,
B and D). The precise temporal concordance of these changes
is consistent with the notion that, as in episodic attacks of
HypoKPP in vivo, the post-acidosis loss of force is caused by a
transient reduction in fiber excitability.
Pharmacologic protection from acidosis-triggered loss of force
Carbonic anhydrase inhibitors have been used clinically to
prophylactically reduce the severity and frequency of episodic
weakness in HypoKPP (Resnick et al., 1968; Tawil et al., 2000).
We tested the efficacy of pretreatment with acetazolamide
(100 µM) to reduce the post-acidosis loss of force for the soleus
muscle. Muscles from the same animal were tested in pairs, one
drug exposed and the other not, to control for the variability of
the force transients. Acetazolamide aggravated the loss of force
for NaV1.4-R669H soleus (Fig. 5 A), whereas partial protection of
∼50% occurred for CaV1.1-R528H mice (Fig. 5 B). This divergent
response has also been observed clinically, with a subset of
NaV1.4-HypoKPP patients (especially R672G or R672S) having a
detrimental effect of acetazolamide and CaV1.1-HypoKPP in-
dividuals receiving benefit or no perceived change (Matthews
Figure 3. Slow kinetics of acidosis-induced loss of force in HypoKPP muscle. (A) The time course for the development of susceptibility to post-acidosis
loss of force was determined by varying the duration of a 25% CO2 challenge (bars, left panel). Plots show average responses from CaV1.1-R528H soleus (6 min:
n = 9, 30 min: n = 6; reproduced from Fig. 2 A; 80min: n = 4). (B) Data were corrected for the decline in force during the 25% CO2 exposure (dashed line, panel A)
to more clearly show the exponential kinetics for the onset of susceptibility with a time constant of 33 min. Plots in the top row show a pairwise comparison
for the transient loss of force induced by a rapid transition of bath pH to 7.4 (blue) versus a slower pH recovery for the soleus from the other hind leg of the
same CaV1.1-R528H mouse in a separate tissue bath (purple). The bottom row shows the bath pH monitored with a reference electrode. Exemplary com-
parisons for the two soleus muscles from a single mouse (left and middle panels) show an attenuation for the loss of force when the pH transition occurred
slowly over 20 min. A slower recovery of bath pH over 50 min prevented the post-acidosis loss of force (right, n = 5).
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et al., 2011). More recently, inhibition of the NKCC1 co-
transporterwith bumetanidewas shown to be highly effective at
preventing or reversing the loss of force associated with a low-K+
challenge (2 mM) in our mouse models of HypoKPP (Wu et al.,
2013a,b). Consistent with this beneficial effect, pretreatment
with 0.5 µM bumetanide completely prevented the post-acidosis
loss of force for both NaV1.4-R669H and CaV1.1-R528H soleus
muscle (Fig. 5, C and D, respectively).
Implication of a chloride dependency for acidosis-induced loss
of force
Loss of fiber excitability caused by a depolarized shift of Vrest
was the final common pathway for episodic attacks of weakness
in all forms of periodic paralysis. For HypoKPP, this depolari-
zation occurred paradoxically in low extracellular K+, where
Vrest exhibited bistability (Cannon, 2010). In other words, Hy-
poKPP fibers may have a normally polarized Vrest with pre-
served excitability or become depolarized and inexcitable (for
the same low value of external K+). The bias between these two
possible states was strongly dependent on the chloride gradient
because skeletal muscle has a very high resting chloride con-
ductance (Geukes Foppen et al., 2002; Cannon, 2018). The
normally low intracellular Cl− (∼3–4 mM) favored the hyper-
polarized Vrest with normal excitability, whereas raised intra-
cellular Cl− (predicted to be 10 to 14 mM) promoted the
depolarized Vrest and weakness. Indeed, the beneficial effect of
bumetanide in preventing loss of force in a low-K+ challenge
for HypoKPP muscle is attributed to an effect on the Cl− gra-
dient (Wu et al., 2013a,b). Bumetanide inhibits the NKCC1 co-
transporter and thereby blocks the major Cl− influx pathway.
The potent efficacy of bumetanide in also preventing post-
acidosis loss of force (Fig. 5, C and D) suggests that this pro-
vocative trigger also involves a rise of intracellular Cl−. We
sought additional experimental evidence to test the notion that
a rise of intracellular Cl− underlies the transient loss of force
after an acidosis challenge.
According to our hypothesis, the deleterious effect of a rise
in myoplasmic Cl− acts through the Cl− conductance (ClC-1) to
produce depolarization and loss of excitability in HypoKPP
fibers. Blocking the ClC-1 with 9-anthracene carboxylic acid
(9-AC) should, therefore, reduce the post-acidosis loss of
force. Consistent with this prediction, pretreatment with
8 µM 9-AC attenuated the loss of force by ∼50% for NaV1.4-
R669H HypoKPP soleus muscle (Fig. 6 A). The partial effect is
Figure 4. HypoKPPmuscle excitability is reduced during the transient loss of force. (A–D) CMAP (A and B) and muscle force (C and D) were measured for
a tetanic stimulation (0.5 ms at 100 Hz for 60 pulses) applied to the sciatic nerve ending once per minute. Insets in each panel show raw data (black trace)
before the 25% CO2 challenge (black arrow) and at the nadir of force (red trace, red arrow). The initial upward deflection for the CMAP is a shock artifact
(clipped) from the stimulating electrode. The decrease in CMAP amplitude is coincident with the transient loss of force for both NaV1.4-R669H (A and C) and
CaV1.1-R528H HypoKPP soleus (B and D). Responses similar to these exemplary traces were observed for two additional trials with each genotype.
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likely attributable to only ∼50% block of ClC-1 (IC50 ∼7 µM;
Astill et al., 1996), which was chosen to minimize a possible
confounding effect from myotonia. This explanation is con-
sistent with the very modest increase for the force relaxation
time (∼30%) in 8 µM 9-AC. An alternative approach is to re-
move Cl− from the extracellular buffer and replace it with the
impermeant anion methanesulfonate. As expected in Cl−-free
conditions, the soleus muscle developed myotonia with a
marked prolongation in relaxation of force at the end of a
tetanic stimulation (Fig. 6 B, inset). Nevertheless, peak force
was maintained, and so it was possible to perform a 25% CO2
challenge. For CaV1.1-R528H HypoKPP muscle the tetanic
force decreased during the period of acidosis, but more im-
portantly, force quickly and fully recovered after a return
to 5% CO2 with no post-acidosis transient loss of force
(Fig. 6 B).
The third line of evidence for ClC-1 involvement is based on
the detection of myotonia as an indicator of a low-conductance
ClC-1 state. Our NaV1.4-M1592V mouse model of HyperKPP had
electromyographic evidence of myotonia at baseline, but some
provocative challenge (e.g., low Ca2+) was required to cause a
delay in muscle force relaxation (Hayward et al., 2008). Aci-
dosis reduced the conductance of ClC-1 (Palade and Barchi,
1977), and a 25% CO2 challenge elicited myotonia as expected
from a decrease in GCl (Fig. 6 C), especially in combination with
the NaV1.4 gain of function caused by M1592V (Cannon and
Strittmatter, 1993). Myotonia was fully reversible, as shown
by the superimposed force transient after returning to 5% CO2.
We used the amplitude of the residual force 100 ms after the
end the stimulus (t = 550 ms in the trace) as a measure of
myotonia and, therefore, indirectly as a measure of reduced
GCl. The time course for the development of and recovery from
myotonia (reduced GCl) is shown in Fig. 6 D (red plot) for a 30-
min challenge with 25% CO2. A typical response for the post-
acidosis loss of force in a HypoKPP muscle (Fig. 6 D, NaV1.4-
R669H, blue plot) is superimposed and shows the close tem-
poral association for the recovery from myotonia (i.e., increase
of GCl back to baseline) and the onset of the transient loss of
force. These data support our proposal that the post-acidosis
loss of force is chloride dependent and triggered by the rapid
increase in GCl when the pH is quickly returned to the
normal range.
Figure 5. Pharmacologic inhibition of the post-acidosis loss of force. (A and B) Pretreatment with acetazolamide (ACTZ; 100 µM) accentuated the loss of
force for NaV1.4-R669H soleus (A; P < 0.05 from 64 to 70min, n = 3) and partially reduced the loss of force for CaV1.1-R528H (B; P < 0.01 from 64 to 90min, n = 8).
(C and D) Bumetanide (BMT; 0.5 µM) completely prevented the post-acidosis loss of force for NaV1.4-R669H (C, n = 3) and CaV1.1-R528H soleus (D, n = 3).
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Discussion
The relation between acidosis and susceptibility to periodic
paralysis has been of interest for nearly 50 years, when it was
proposed that the beneficial effect of carbonic anhydrase in-
hibitors on reducing the frequency and severity of attacks in
HypoKPP may be a consequence of metabolic acidosis produced
from bicarbonate loss in the urine (Griggs et al., 1970). Sup-
porting evidence that systemic metabolic acidosis is a plausible
mechanism for the beneficial effect of carbonic anhydrase in-
hibitors was obtained by inducing metabolic acidosis using a
completely different mechanism (administering oral NH4Cl),
which also decreased the severity of HypoPP (Jarrell et al., 1976).
Interpretation of how metabolic acidosis reduces the severity of
HypoKPP in patients is confounded by multiple homeostatic
mechanisms operating in vivo (Matthews and Hanna, 2010). For
example, in individuals with HypoKPP, acidosis inhibits the
shift of K+ into muscle in response to a glucose plus insulin
challenge (Vroom et al., 1975). So, is the beneficial effect of ac-
idosis secondary to attenuating the decrease in extracellular
K+—a known trigger for weakness in HypoKPP—or some other
mechanism by which acidosis preserves muscle fiber excitabil-
ity? Our data provide additional information because extracel-
lular [K+] was clamped in the ex vivo tissue bath. Consistent
with these prior studies in patients, acidosis induced by
Figure 6. The chloride conductance contributes to the post-acidosis loss of force in HypoKPP muscle. (A) Partial block of ClC-1 with 8 µM 9-AC at-
tenuated the transient loss of force (NaV1.4-R669H, n = 3). (B) In a Cl−-free bath, peak isometric force was maintained (e.g., 20–50min), and the force transient
showed pronounced myotonia (inset shows superimposed responses at the times indicated by arrows). While there was a loss of force during the 25% CO2
challenge compared with contralateral soleus muscle in a separate Cl− bath (50–80 min), the post-acidosis loss of force did not occur (filled triangles, 80–100
min, n = 3). (C) Superimposed contractions show myotonia with delayed relaxation in 25% CO2 for HyperKPP NaV1.4-M1592V soleus that reverses upon return
to 5% CO2. (D) Overlay of the time course for acidosis-induced myotonia in HyperKPP soleus (red) and post-acidosis loss of force for HypoKPP NaV1.4-R669H
soleus (blue) shows the loss of force in HypoKPP muscle is coincident with the rapid recovery from myotonia in HyperKPP muscle.
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hypercarbia provides modest protection from loss of force in a
controlled 2 mMK+ challenge (Fig. 1 A). This observation implies
some of the beneficial effect of acidosis occurs directly on
muscle, independent from blunting the hypokalemia induced by
carbohydrate ingestion.
The major finding of this study, however, is the marked loss
of force in HypoKPP muscle that occurs after recovery from
acidosis (Figs. 2, 3, 4, 5, and 6). This phenomenon is extremely
robust. The loss of force induced by recovery from acidosis oc-
curs more consistently than the canonical loss of force with a
low-K+ challenge (e.g., 2 mM). Put another way, from the results
of a single trial with a 25% CO2 challenge, it is possible to predict
with near 100% accuracy whether the soleus muscle was from a
HypoKPP or a WT mouse. The loss of force is biologically rele-
vant. First, the magnitude is substantial and is therefore ex-
pected to adversely impact motor function. Second, the
threshold for inducing a loss of force occurs within the range pH
changes attainable in vivo. We have reported the change in
external pH capable of inducing a loss of force (Fig. 2 C), whereas
the pHi is likely to be the relevant value (see below). The change
of pHi for muscle is typically 45% of the value imposed extra-
cellularly by an increase in the percentage of CO2 (de Paoli et al.,
2007), and this estimate agrees with our observed 0.4-U intra-
cellular decrease with a 25% CO2 challenge (Fig. 2 B) corre-
sponding to a 0.8-U decrease in extracellular pH. Exercise to
exhaustion in humans produces a 0.5-U decrease of pHi in active
muscle (Sahlin et al., 1976), which is approximately equivalent to
the 25% CO2 challenge in our ex vivo experiments that produced
an ∼60% loss of force (Figs. 2, 3, and 5).
The post-acidosis loss of force in HypoKPP muscle shares
several features with the stereotypical episodes of impaired
contractility that are triggered by a low-K+ challenge. First,
muscle excitability is reduced during the period of post-acidosis
loss of force (Fig. 4). This observation is consistent with the
central dogma that acute attacks of periodic paralysis are caused
by sustained depolarization of Vrest that inactivates sodium
channels and thereby reduces excitability (Rüdel et al., 1984;
Cannon, 2015). Second, pharmacologic interventions that mod-
ify the loss of force in a low-K+ challenge have similar effects on
the post-acidosis loss of force. Pretreatment with bumetanide
completely prevents the loss of force for both types of provoc-
ative challenge and in both CaV1.1-R528H and NaV1.4-R669H
HypoKPP muscle (Fig. 5, C and D). Moreover, acetazolamide
exacerbates the post-acidosis loss of force in mouse NaV1.4-
R669H soleus muscle (Fig. 5 A) and worsens HypoKPP attack
frequency and severity in patients with R/G or R/S mutations in
S4DII of NaV1.4 (Sternberg et al., 2001; Matthews et al., 2011).
Conversely, with HypoKPP from CaV1.1-R528H acetazolamide
partially protects against post-acidosis loss of force (Fig. 5 B) and
reduces HypoKPP attacks in patients. As presented in the In-
troduction, acetazolamide is thought to act by promoting met-
abolic acidosis in the whole animal, and so it is remarkable that
an effect was observed ex vivo. While acetazolamide does not
have much of an effect on the steady-state pH gradient across
the fiber in the organ bath, the inhibition of carbonic anhydrase
will slow the rate of pHi equilibration in response to a change
in the percentage of CO2 (Leem and Vaughan-Jones, 1998). As
shown in Fig. 3, a slower rate of recovery from acidosis (and
hence slower intracellular alkalization) reduces the risk of
triggering a loss of force, and this is a plausible explanation for
the modest protection in the case of CaV1.1-R528H (Fig. 5 B). On
the other hand, the basis for an increased loss of force with
acetazolamide for NaV1.4-R669H remains to be established. One
marked difference between the two HypoKPP models is that
NaV1.4-R669H has a proton-selective gating pore leak, while the
gating pore for CaV1.4-R528H is weakly selective for monova-
lent cations. Perhaps, in the presence of acetazolamide, a rapid
bath exchange causes a transient pH gradient that increases the
inward proton current in the NaV1.4-R669H gating pore and
thereby promotes a shift to the depolarized bistable state of Vrest?
Additional experiments are needed to test these ideas. Taken
together, however, these overlapping features that are shared
for the loss of force provoked by low K+ or by recovery from
acidosis suggest that both triggers lead to a common pathological
state of impaired muscle function.
We propose a mechanism by which recovery from acidosis
produces a transient loss of force in HypoKPP muscle and pre-
sent this notion in the context of exercise-induced attacks of
weakness. Our proposed mechanism has two critical compo-
nents. First, acidosis reduces the chloride conductance of the
sarcolemma (Palade and Barchi, 1977; Pedersen et al., 2004,
2005). Second, in HypoKPP muscle with a bistable Vrest, low
[Cl]in favors the hyperpolarized potential whereas high [Cl]in
favors the depolarized state (Fig. 5 in Geukes Foppen et al., 2002;
Cannon, 2018). This scheme is illustrated with the four-state
diagram in Fig. 7. The top left quadrant represents the base-
line resting state with a normal Vrest, GCl, and [Cl]in. In Fig. 7,
horizontal transitions represent a change in pH caused by ex-
ercise (rightward, producing acidosis) or rest (leftward, recov-
ering from acidosis). Vertical transitions represent a change of
[Cl]in, with downward movement indicating an increase and
upward being a decrease. We propose the pH changes are rela-
tively fast (with abrupt changes in level of exercise or bath
Figure 7. Proposed scheme for post-acidosis loss of force in HypoKPP
muscle. Four states are depicted, with the basal conditions in the top left
quadrant. Exercise promotes horizontal transitions to the right (acidosis),
whereas rest favors a leftward shift back to the resting state. The build-up of
susceptibility to post-acidosis weakness occurs on the right side, with a slow
progressive shift to the bottom right quadrant as [Cl]in increases. Recovery
from acidosis into the bottom left state (right to left transition in the bottom
row) depolarizes Vrest because GCl recovers with a high [Cl]in. In HypoKPP
fibers, the bistable Vrest keeps the fiber depolarized and [Cl]in high. For WT
fibers, Vrest repolarizes, and the large driving force on Cl− through ClC-1
channels causes [Cl]in to rapidly return to the resting level.
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exchange in our isolated muscle experiments) compared with
the slow accumulation for [Cl]in, which is limited by the influx
rate of NKCC1 cotransporter and the surface area to volume for
the myoplasm. Conversely, the washout of high [Cl]in after re-
covery to normal pH (and high GCl) is much faster because under
a sufficient driving force through ClC-1 channels, Cl− efflux rate
is much higher.
Starting from the baseline top left quadrant in Fig. 7, exercise
promotes a shift to the top right where acidosis rapidly decreases
GCl and thereby causes a mild hyperpolarization of Vrest by a few
millivolts because ECl is slightly depolarized from the normal
Vrest (Aickin et al., 1989). If the exercise period is brief, then the
process is quickly reversible and the muscle recovers back to the
top left quadrant. With prolonged periods of exercise (e.g., tens
of minutes), [Cl]in increases because Cl− influx via NKCC1 ex-
ceeds efflux through ClC-1 with a reduced GCl. These changes are
depicted as a slow shift down to the bottom right quadrant. If
exercise is now abruptly stopped (i.e., the acidosis is rapidly
reversed), then GCl rapidly increases. With the persistently high
ratio of [Cl]in/[Cl]out, the depolarized ECl promotes a shift of Vrest
to the depolarized state of the bistable system in HypoKPP
muscle (bottom left quadrant). From this depolarized Vrest, so-
dium channels are inactivated, thereby causing reduced excit-
ability and loss of force. This anomalous depolarization also
keeps [Cl]in higher than baseline in HypoKPP fibers. In WT fi-
bers, with GCl now increased back to its basal level, Cl− efflux
through ClC-1 now exceeds influx through NKCC1, and [Cl]in
rapidly decreases until the baseline (top left) is reestablished and
the net Cl− flux is zero.
Several experimental observations presented herein are
consistent with the mechanism proposed in Fig. 7. (1) Inhibition
of NKCC1 with bumetanide prevents the post-acidosis loss of
force (Fig. 5, C and D). Eliminating Cl− influx via NKCC1 will
prevent the build-up of [Cl]in in the low-GCl state (transition
from top right to bottom right in Fig. 7). (2) Partial block of ClC-1
with 9-AC attenuates the loss of force (Fig. 6 A). When GCl re-
mains low in 9-AC (independent of ΔpH), then the consequences
of [Cl]in shifts on Vrest are attenuated. (3) Cl−-free conditions
abolish the post-acidosis loss of force (Fig. 6 B). With no Cl−,
there can be no shift to the high-[Cl]in state (bottom row in
Fig. 7). We propose the immediate loss of force (∼40% drop) in
25% CO2 in Fig. 6 B is likely due to a pH-dependent decrease of
the inward rectifier conductance (Blatz, 1984). This GKir change
minimally affects Vrest (and therefore force) when Cl− is present
because ClC-1 keeps Vrest near ECl. In the absence of Cl−, however,
then a modest decrease in GKir plus the gating pore leak of Hy-
poKPP muscle produce depolarization and loss of force. (4) The
kinetics for the onset of susceptibility to loss of force, the rela-
tively fast drop in force, and duration of weakness are consistent
with the model. The onset of susceptibility occurs very slowly,
with a time constant of 33 min (Fig. 3 A), because the rate for the
increase of [Cl]in is limited by the relatively small influx rate via
NKCC1 cotransporter of ∼20 pmol/(cm2-s) (Gallaher et al.,
2009). This is depicted by the slow transition from the top
right to bottom right in Fig. 7. Conversely, the recovery from a
transient loss of force occurs more quickly because the Cl− efflux
rate via the ClC-1 channel is much higher compared with the
cotransporter (transition from bottom left to top left in Fig. 7).
With an abrupt recovery of pH, the loss of force occurs relatively
quickly with a large decrease in the first 2 min (Figs. 2 and 3).
This rapid loss of force is consistent with our proposed rapid
recovery of GCl (transition from bottom right to bottom left in
Fig. 7), and is supported experimentally by the rapid loss of
myotonia in HyperKPP muscle (Fig. 6 D). (5) The model is also
consistent with the absence of a post-acidosis loss for force for
HyperKPP muscle (Fig. 2 A). The importance of the Cl− gradient
occurs in the context of a bistable Vrest created by the presence of
an anomalous gating pore conductance, which is the essential
defect of mutant NaV1.4 or CaV1.1 channels in HypoKPP (Cannon,
2018).
This initial report that a rapid recovery from acidosis triggers
a robust loss of force in HypoKPP muscle has practical im-
plications for the management of patients. First, these data
clearly document the perils of resting motionless after a period
of vigorous exercise—an activity notorious for eliciting an acute
attack of HypoKPP. Second, they explain why a slowwarmdown
after exercise may prevent triggering an attack of weakness.
Moreover, the connection to pH suggests that simply increasing
pCO2 by rebreathing into a paper bag may ameliorate an im-
pending attack. Third, this study supports the notion that mild
acidosis may be part of the mechanism of action for carbonic
anhydrase inhibitors in the prophylactic reduction of attack
frequency and severity. While this study implicates recovery
from acidosis as a likely contributing factor to postexercise
weakness in periodic paralysis, additional mechanisms must be
involved, for example, to account for the fact that postexercise
weakness is also a prominent feature of HyperKPP.
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